Congenital Hypothyroidism

Ari J Wassner1

  • 1Thyroid Program, Division of Endocrinology, Boston Children's Hospital, Harvard Medical School, 300 Longwood Avenue, Boston, MA 02115, USA.

Clinics in Perinatology
|February 7, 2018
PubMed

Insights

Early detection and treatment of congenital hypothyroidism (CH) are vital for preventing neurodevelopmental issues. Newborn screening, while effective, requires vigilance for high-risk infants to ensure optimal outcomes.

Area of Science:

  • Pediatrics
  • Endocrinology
  • Genetics

Background:

  • Congenital hypothyroidism (CH) is a prevalent endocrine disorder in newborns.
  • Untreated CH can lead to severe neurodevelopmental deficits and impaired growth.
  • Early identification and intervention are crucial for positive long-term health outcomes.

Purpose of the Study:

  • To emphasize the importance of prompt diagnosis and treatment of congenital hypothyroidism.
  • To highlight the role and limitations of universal newborn screening for CH.
  • To underscore the need for clinical suspicion and further evaluation in high-risk infants.

Main Methods:

  • Review of current literature on congenital hypothyroidism diagnosis and management.
  • Analysis of the effectiveness of universal newborn screening programs.
  • Discussion of etiological factors and diagnostic approaches for CH.

Main Results:

  • Universal newborn screening is a key tool for detecting CH, but not infallible.
  • High-risk infants may require repeat screening or heightened clinical suspicion.
  • Identifying the etiology of CH aids in prognosis and treatment planning.

Conclusions:

  • Prompt diagnosis and consistent treatment with levothyroxine are essential for optimal neurodevelopmental outcomes in infants with CH.
  • A combination of screening, clinical vigilance, and thorough evaluation ensures comprehensive care for congenital hypothyroidism.
  • Early and adequate treatment significantly mitigates the long-term morbidity associated with CH.

Related Concept Videos